http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105622661-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-584 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J29-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J29-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08 |
filingDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105622661-B |
titleOfInvention | A kind of molecular sieve catalytic synthetic method of Ezetimibe intermediate |
abstract | This application discloses a kind of Ezetimibe intermediate 3 [(2R, 5S) 5 (4 fluorophenyl) 2 [(S) [(4 fluorophenyls (amino)]] [4 R 1 Oxygroup] phenyl] methyl] 1 oxo 5 [(trimethyl silicane) oxygen] phenyl] 4 phenyl (4S) 2 oxazolidone synthetic method, by using 5 molecular sieve catalysts of solid H ZSM and/or 5 molecular sieve catalysts of Co ZSM instead of original titanium tetrachloride and isopropyl titanate catalyst, reduce environmental pollution and the requirement to production equipment, solve the problems, such as the separation of catalyst and recycling, the large-scale continuous production for Ezetimibe is laid a good foundation. |
priorityDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.